The Business Research Company’s report on the Open-Angle Glaucoma (OAG) Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
Which emerging drivers are set to accelerate the growth of the open-angle glaucoma (oag) market further?
The growing awareness of eye illnesses is expected to propel the growth of the open-angle glaucoma (OAG) market going forward. Eye illnesses encompass medical conditions impacting the structure, function, or vision of the eyes, ranging from minor concerns such as dry eye to serious diseases such as glaucoma and macular degeneration. Their prevalence is rising due to aging populations, prolonged screen exposure, increasing diabetes cases, environmental pollution, and lifestyle habits that strain eye health. Open-angle glaucoma (OAG), a leading cause of blindness, especially among older adults, underscores the critical need for routine eye exams, early diagnosis, and proactive treatment to safeguard against irreversible vision loss. For instance, in October 2023, according to the Royal National Institute of Blind People (RNIB), a UK-based sight loss charity, eye care outpatient appointments in the UK exceeded eight million in 2021/22, making it the most in-demand specialty. Additionally, the number of individuals with sight loss, currently surpassing two million, is projected to double to over four million by 2050. Therefore, the growing awareness of eye illnesses is driving growth in the open-angle glaucoma (OAG) market.
Access Your Free Sample of the Global Open-Angle Glaucoma (OAG) Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=20911&type=smp
What are the key factors influencing the forecasted market size of the open-angle glaucoma (oag) industry?
The open-angle glaucoma (OAG) market size has grown strongly in recent years. It will grow from $6.13 billion in 2024 to $6.55 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to the increasing prevalence of glaucoma among aging populations, growing awareness about early detection of eye diseases, rising healthcare expenditure, government initiatives for vision care programs, and expansion of ophthalmology practices globally.
The open-angle glaucoma (OAG) market size is expected to see strong growth in the next few years. It will grow to $8.42 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to increasing demand for combination therapies, rising focus on personalized medicine, improved reimbursement policies for glaucoma treatments, increasing prevalence of lifestyle-induced ocular conditions, and rising demand for non-invasive diagnostic methods. Major trends in the forecast period include growing adoption of AI in glaucoma diagnostics, a shift toward outpatient glaucoma surgical procedures, increasing use of sustained-release glaucoma implants, rising integration of wearable technology for monitoring intraocular pressure, and heightened focus on sustainability in medical device manufacturing.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=20911&type=smp
Who are the leading competitors in the open-angle glaucoma (oag) market?
Major companies operating in the open-angle glaucoma (OAG) market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc, Novartis AG, Amgen Inc., Teva Pharmaceutical Industries Ltd., Boston Scientific, Alcon Inc., Bausch Health Companies Inc., Hoya Corporation, Sun Pharmaceutical Industries Ltd., Santen Pharmaceuticals, Mallinckrodt Pharmaceuticals, Théa Pharma, Glaukos Corporation, Quantel Medical, EyePoint Pharmaceuticals Inc., iSTAR Medical, Nicox Ophthalmics, Visus Therapeutics, Peregrine Eye Laser and Institute, Inotek Pharmaceuticals
Which emerging trends are set to transform the open-angle glaucoma (oag) market landscape?
Major companies operating in the open-angle glaucoma (OAG) market are prioritizing the development of innovative solutions, such as minimally invasive glaucoma devices (MIGDs), to provide advanced and less invasive alternatives for managing primary open-angle glaucoma while reducing reliance on traditional treatments. A minimally invasive glaucoma device (MIGD) refers to a range of surgical implants and techniques designed to lower intraocular pressure in glaucoma patients through small incisions and minimal disruption of ocular tissues. For instance, in December 2023, iSTAR Medical, a Belgium-based medtech company, launched MINIject in the Netherlands. This bio-integrating treatment for primary open-angle glaucoma utilizes a unique porous STAR material to enhance fluid outflow and reduce IOP. By decreasing dependency on conventional therapies, MINIject represents a significant breakthrough in glaucoma care, offering a safer and more effective management option for this leading cause of permanent blindness.
How do different geographies compare in terms of market share and growth potential in the open-angle glaucoma (oag) market?
North America was the largest region in the open-angle glaucoma (OAG) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the open-angle glaucoma (OAG) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Order Your Report Now For Swift Delivery
https://www.thebusinessresearchcompany.com/report/open-angle-glaucoma-oag-global-market-report
Which major segments of the open-angle glaucoma (oag) market are experiencing the fastest growth?
The open-angle glaucoma (OAG) market covered in this report is segmented –
1) By Disease Type: Open Angle Glaucoma, Angle Closure Glaucoma, Other Disease Type
2) By Drug Class: Prostaglandin Analog, Beta Blockers, Adrenergic Agonist, Carbonic Anhydrase Inhibitors, Others Drug Class
3) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
Subsegments:
1) By Open Angle Glaucoma (OAG): Primary Open-Angle Glaucoma (POAG), Secondary Open-Angle Glaucoma
2) By Angle Closure Glaucoma: Acute Angle-Closure Glaucoma, Chronic Angle-Closure Glaucoma
3) By Other Disease Type: Normal-Tension Glaucoma, Congenital Glaucoma, Secondary Glaucoma
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20911
How is the open-angle glaucoma (oag) market defined, and what are its core characteristics?
Open-angle glaucoma (OAG) is a chronic, progressive eye condition characterized by the gradual clogging of the drainage canals in the eye, leading to increased intraocular pressure that damages the optic nerve, often without noticeable symptoms until significant vision loss occurs. Its treatment aims to lower intraocular pressure, thereby preventing optic nerve damage and preserving vision through medications, laser procedures, or surgical interventions.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
